TrialJournal of acquired immune deficiency syndromes (1999)2019

Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations.

Alexander Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.